Healthcare Sector — Q3 FY24 Earnings Overview
3 companies reported. 3 bullish, 0 neutral, 0 bearish.
Average revenue growth: 12.5%
Sector sentiment: bullish
Aggregate revenue: ₹23,836 Cr
Average margin: 22.3%
Company Results
| Company | Revenue | YoY | Margin | Sentiment |
|---|---|---|---|---|
| Sunpharma | ₹12,381 Cr | +9.5% | 28.0% | bullish medium |
| Cipla | ₹6,604 Cr | +14% | 26.0% | bullish high |
| Apollohosp | ₹4,851 Cr | +14% | 13.0% | bullish high |
Key sector risks this quarter
Sunpharma · high
Supplies from Mohali plant are not normal; issues with product prioritization and quality clearances are causing delays.
Sunpharma · highThe $43/share offer requires approval from Taro's minority shareholders; failure could derail the merger.
Cipla · highIndore facility received a warning letter citing Albuterol complaints; resolution timeline uncertain and may impact future approvals.
Cipla · highGoa facility due for re-inspection; delay or adverse outcome could further delay Abraxane launch.
Sunpharma · mediumCEQUA's market share has declined due to generic Restasis and new entrants with different mechanisms of action.